Answer
Yes, Winlevi (clascoterone) cream may suppress the hypothalamic-pituitary-adrenal axis during or after treatment; all affected participants in Phase 2 maximum-use trials returned to normal function four weeks after stopping treatment.
Sources for this answer
- Winlevi 10 mg/g creamGlenmark Pharmaceuticals Europe Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 1Document updated
Sources checked